ritonavir
Generic: ritonavir
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
ritonavir
Generic Name
ritonavir
Labeler
bryant ranch prepack
Dosage Form
TABLET
Routes
Active Ingredients
ritonavir 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63629-5702
Product ID
63629-5702_0e75bb69-7cef-4bd2-80c0-ac6cba7a1266
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204587
Listing Expiration
2026-12-31
Marketing Start
2018-09-17
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
636295702
Hyphenated Format
63629-5702
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ritonavir (source: ndc)
Generic Name
ritonavir (source: ndc)
Application Number
ANDA204587 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 15 TABLET in 1 BOTTLE (63629-5702-1)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0e75bb69-7cef-4bd2-80c0-ac6cba7a1266", "openfda": {"nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117"], "unii": ["O3J8G9O825"], "rxcui": ["900575"], "spl_set_id": ["3c811e3e-f685-4af7-a4d1-037f2613ee68"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (63629-5702-1)", "package_ndc": "63629-5702-1", "marketing_start_date": "20250605"}], "brand_name": "Ritonavir", "product_id": "63629-5702_0e75bb69-7cef-4bd2-80c0-ac6cba7a1266", "dosage_form": "TABLET", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inducers [MoA]"], "product_ndc": "63629-5702", "generic_name": "Ritonavir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ritonavir", "active_ingredients": [{"name": "RITONAVIR", "strength": "100 mg/1"}], "application_number": "ANDA204587", "marketing_category": "ANDA", "marketing_start_date": "20180917", "listing_expiration_date": "20261231"}